- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Video and telephone consultations
- Home chemotherapy
I qualified from Guy's Hospital Medical School, London in 1993 and trained in general medicine in the South East of England. I completed my oncology training in 2003, and was appointed as a Consultant Oncologist in South Wales the same year. I am Chair of the Medical Advisory Committee at the Rutherford Cancer Centre, Newport.
Areas of interest
Proton Beam Therapy for urological and lung cancers; Non-surgical treatment of lung cancer, mesothelioma and urological cancers (prostate, kidney and bladder cancer);
Chemotherapy and targeted therapy for lung and urological cancers; Stereotactic radiotherapy for early lung cancer; Combined modality therapy for locally advanced lung cancer; Brachytherapy for prostate cancer; IMRT / IGRT radiotherapy for prostate cancer; Bladder sparing treatment for bladder cancer
Current NHS consultant posts held
Consultant Clinical Oncologist South West Wales Cancer Centre, Swansea Bay NHS Trust.
Radiotherapy dose escalation in locally advanced non-small cell lung cancer: Chief investigator for the I-START trial
Vaccine therapy for malignant pleural mesothelioma: Chief investigator for the SKOPOS trial
The effect of radiotherapy on Implantable cardiac devices
Proton Beam Therapy in Mesothelioma
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
Shah R, Lester JF.
Clin Lung Cancer. 2019 Dec 20.
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, Dubois D, McKinna F, Foran B, Madhavan K, MacGregor C, Bates A, O'Rourke N, Lester JF, Sevitt T, Roos D, Dixit S, Brown G, Arnott S, Thomas SS, Forsyth S, Beare S, Reczko K, Hackshaw A, Lopes A
JAMA. 2019 Dec 3;322(21):2084-2094
Courses offered to GPs
I give regular talks to local and regional GPs on any aspect of lung cancer and urological cancer management. Please contact my secretary for further information.
- Member of the Royal College of Physicians Royal College of physicians 1997
- Bachelor of Medicine, Bachelor of Surgery London 1993
- Fellow of the Royal College of Radiologists Royal College of Radiologists 2001
Reference number 4040325
Professional bodies (positions held - last 3 yrs)
- Committee member NCRI lung cancer advanced disease subgroup 2011
- Committee member British Thoracic Oncology Steering Group 2011
Details of entry to specialist register
- Clinical Oncology , 2003
Affiliations / memberships
Mesothelioma research Network member
2018 to date
UK Lung Cancer Consortium committee member
2017 to date
British Thoracic Oncology Group steering committee
2011 to date
NCRI Advanced Diseases Subgroup
2013 to date
Fellow of the Royal College of Radiologists
2001 to date
- Genesis Care Centre - Bristol
- 09:00 - 12:00
- 01454 642802
- Sancta Maria Hospital
- 15:00 - 20:00
- 07570 131438
- St Joseph's Hospital - Newport
- 14:00 - 20:00
- 01633 820300
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Genesis Care have a 24 hour on call service
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (>50)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (5-50)
GenesisCare, Bristol (1-5)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (5-50)
GenesisCare, Bristol (5-50)
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
GenesisCare, Bristol (1-5)
- Show All (11 )...